Company KAI Biotech Co., LTD.

Equities

A446600

KR7446600009

Biotechnology & Medical Research

End-of-day quote Korea S.E. 06:00:00 2024-02-18 pm EST 5-day change 1st Jan Change
6,340 KRW -.--% Intraday chart for KAI Biotech Co., LTD. -.--% -71.18%

Business Summary

Kai BioTech Co Ltd is a Korea-based company mainly engaged in the medical business based on radioactive fusion technology. The Company is engaged in the manufacture and sale of radiopharmaceuticals used in the diagnosis of oncology, prostate, liver, lung and brain cancers as well as others. The Company is also engaged in the manufacture and sale of pheochromocytoma treatment, liver cancer treatment and other products.

Managers

Managers TitleAgeSince
Chief Executive Officer 52 12-11-30
Comptroller/Controller/Auditor 68 14-07-31

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 52 12-11-30
Director/Board Member 51 17-06-30
Director/Board Member 58 12-11-30
Director/Board Member 54 18-11-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 45,455 0 0 24.64 %
Stock B 1 981,281 241,800 ( 24.64 %) 0
Stock C 0 45,455 0 0

Company contact information

KaiBioTech Co., Ltd.

567 Baekje-daero Deokjin-gu

54896, Jeonju-si

+

http://www.kaibiotech.com
address KAI Biotech Co., LTD.(A446600)
  1. Stock Market
  2. Equities
  3. A446600 Stock
  4. Company KAI Biotech Co., LTD.